Clinical Characteristics and Outcomes of COVID-19 Acute Respiratory Distress Syndrome (ARDS) Survivors in Early Pandemic: A Single Healthcare System Retrospective Study
Authors:
- Cyrus A VahdatpourCVCyrus A Vahdatpour
- Sheila De YoungSYSheila De Young
- Johnny F. JaberJJJohnny F. Jaber
- Joy AyyoubJAJoy Ayyoub
- Thomas SommersTSThomas Sommers
- Christopher WenCWChristopher Wen
- Tristan LimTLTristan Lim
- Olutosin OwoyemiOOOlutosin Owoyemi
- Kathleen DavinKDKathleen Davin
- Paul KinniryPKPaul Kinniry
- Onyeka NwankwoONOnyeka Nwankwo
- Adam AustinAAAdam Austin
Open Access
- 13 July 2022
- journal article
- research article
- Published by Springer Nature in Cureus
- Vol. 14 (7) , e26801
Abstract
Introduction: Acute respiratory distress syndrome (ARDS) management in the intensive care unit (ICU) has attracted strong interest since the start of the COVID-19 pandemic. Our retrospective study aims to describe the outcomes and predictors of mortality of ARDS associated with COVID-19 within one university-based healthcare system. Methods: We identified 165 patients within our healthcare system during the months of April 2020 through July 2020, who were admitted to our medical ICUs and eligible for our study. Baseline patient characteristics, ICU and hospital course information, ICU interventions, ventilator settings, and hospital complications were collected and analyzed using descriptive statistical techniques. Results: Our cohort had an average age of 64. No significant difference in mortality was identified with male vs. female gender or BMI. Most of the patient cohort was identified as black (68.2%). The overall mortality of our cohort was 38.2%. Hyperlipidemia, coronary artery disease, and chronic obstructive pulmonary disease were all associated with higher mortality. There was a significant difference in mortality between those with higher observed ventilator plateau pressures at 24 hours and higher driving pressures at 24 hours. Conclusion: COVID-19-associated ARDS is associated with significant mortality. Physicians should be aware of pre-existing conditions potentially related to worse outcomes so that they receive an appropriate level of care in a timely manner. Ventilator management should focus on maintaining low intra-thoracic pressure changes. Prospective studies are needed to guide COVID-19-associated ARDS management.Keywords
This publication has 18 references indexed in Scilit:
- Risk Factors Associated With Mortality Among Patients With COVID-19 in Intensive Care Units in Lombardy, ItalyJAMA Internal Medicine, 2020
- Underlying respiratory diseases, specifically COPD, and smoking are associated with severe COVID-19 outcomes: A systematic review and meta-analysisRespiratory Medicine, 2020
- Methylprednisolone as Adjunctive Therapy for Patients Hospitalized With Coronavirus Disease 2019 (COVID-19; Metcovid): A Randomized, Double-blind, Phase IIb, Placebo-controlled TrialClinical Infectious Diseases, 2020
- Clinical features, ventilatory management, and outcome of ARDS caused by COVID-19 are similar to other causes of ARDSIntensive Care Medicine, 2020
- Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort studyThe Lancet, 2020
- The impact of COPD and smoking history on the severity of COVID‐19: A systemic review and meta‐analysisJournal of Medical Virology, 2020
- Prevalence, Severity and Mortality associated with COPD and Smoking in patients with COVID-19: A Rapid Systematic Review and Meta-AnalysisPLOS ONE, 2020
- Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational studyThe Lancet Respiratory Medicine, 2020
- Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, ItalyJAMA, 2020
- Acute Respiratory Distress SyndromeJAMA, 2012